Final step, call it toasted and done.
Of course, the Senior Management make a profit at each step- clown shoes flapping all the way to the bank.
They followed this up by closing down their most productive R& D sites globally.
Vast personal profit for the execs, decades of experienced researchers tossed to the wind, and their "if we screened X million candidates with this robotic platform and got N useful hits, if we screen X^5 million via robotic screen we'll get N^5 final candidates and reap the rewards" strategy didn't work worth a darn. Big surprise.
That's what happens when suits (some hired from companies with a GREAT track record for drug development- like.... McDonalds) take over a scientific company.
A few more rounds of boosting stock price via layoffs and this will be a little has-been of a company.
Nice work there guys. Way to destroy a company. You could have done the same thing by just buying a pizza chain or something and selling off assets for personal gain, and not cost the real human race useful medications.
In every non-trivial program there is at least one bug.